US Patent Issued to NEXEL on July 14 for "Polypeptide for preventing or treating idiopathic pulmonary fibrosis and pharmaceutical composition containing the same" (South Korean Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,867, issued on July 14, was assigned to NEXEL Co. LTD. (Seoul, South Korea).

"Polypeptide for preventing or treating idiopathic pulmonary fibrosis and pharmaceutical composition containing the same" was invented by Choongseong Han (Seoul, South Korea), Donghun Woo (Seoul, South Korea), Minkyung Kim (Seoul, South Korea), Junghyuck Park (Seongnam-si, South Korea), Joonchul Kim (Seoul, South Korea) and Geunho An (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a polypeptide for preventing or treating idiopathic pulmonary fibrosis, which is synthesized by linking 9 to 10 amino acids together and comprises...